Works by Shepard, Dale R


Results: 15
    1

    A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.

    Published in:
    Oncologist, 2019, v. 24, n. 9, p. 1151, doi. 10.1634/theoncologist.2018-0749
    By:
    • Michaelson, M. Dror;
    • Gupta, Shilpa;
    • Agarwal, Neeraj;
    • Szmulewitz, Russell;
    • Powles, Thomas;
    • Pili, Roberto;
    • Bruce, Justine Yang;
    • Vaishampayan, Ulka;
    • Larkin, James;
    • Rosbrook, Brad;
    • Wang, Erjian;
    • Murphy, Danielle;
    • Wang, Panpan;
    • Lechuga, Maria Josè;
    • Valota, Olga;
    • Shepard, Dale R.
    Publication type:
    Article
    2
    3
    4

    A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 485, doi. 10.1007/s00280-021-04308-z
    By:
    • Saif, Muhammad Wasif;
    • Becerra, Carlos R.;
    • Fakih, Marwan G.;
    • Sun, Weijing;
    • Popovic, Lazar;
    • Krishnamurthi, Smitha;
    • George, Thomas J.;
    • Rudek, Michelle A.;
    • Shepard, Dale R.;
    • Skopek, Jiri;
    • Sramek, Vladimir;
    • Zaric, Bojan;
    • Yamamiya, Ikuo;
    • Benhadji, Karim A.;
    • Hamada, Kensuke;
    • He, Yaohua;
    • Rosen, Lee
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15